Five data barriers to safer small molecule drug development and how to overcome them

Advancing small molecules from idea to candidate hinges on speed, clarity, and early high-stakes decisions. Yet as discovery workflows grow more complex and data volumes expand, it becomes harder for medicinal chemists to access the insights needed to accelerate R&D and advance candidates with confidence.

In this white paper, we map out five data challenges slowing your R&D endeavors to help you identify friction points, explore actionable solutions, and uncover how integrated, purpose-built discovery platforms can break down data barriers to support smarter design decisions in small molecule drug discovery.